In recent genetic studies [25] three HLA-DRB1 alleles (*15:01, *16:01, *15:02), belonging to the immunologically well characterized DR2 serological group, were analyzed to investigate their association to MS in Sardinian population. Here, HLA-DRB1 is linked to myeloid sarcoma.